Grand Opening Smithtown Coming Soon
FDA-Approved Weight Loss Medications We Offer
Oral Wegovy
Injectable Zepbound
Injectable Wegovy
Injectable Wegovy
Injectable Zepbound
Injectable Wegovy
Injectable Zepbound
Injectable Zepbound
Injectable Zepbound
Oral Wegovy
Oral Wegovy is an FDA-approved semaglutide pill for weight loss. It offers a non-injectable option for adults who qualify for chronic weight management treatment. It is taken once daily exactly as directed, following the FDA-approved prescribing instructions for timing and administration.
How to take it:
Oral Wegovy should be taken exactly as prescribed and according to the package instructions. Because semaglutide tablets have specific administration requirements, patients should follow directions closely for best absorption and effectiveness.
Common side effects:
Side effects may include nausea, vomiting, diarrhea, constipation, stomach discomfort, bloating, decreased appetite, reflux, headache, and fatigue. Gastrointestinal side effects are often more noticeable when first starting treatment or increasing dose.
Contraindications:
Oral Wegovy should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or a serious hypersensitivity reaction to semaglutide. It should also be avoided in pregnancy.
Injectable Wegovy
Injectable Wegovy is a once-weekly semaglutide injection FDA-approved for chronic weight management and also approved in certain adults with cardiovascular disease and obesity or overweight to reduce risk of major cardiovascular events. It is one of the best-known prescription options for patients seeking doctor-supervised weight loss in Suffolk County, NY.
How to take it:
Injectable Wegovy is started at a low weekly dose and gradually increased over time to improve tolerability. It is given once weekly on the same day each week, with or without food, as directed by your provider.
Common side effects:
The most common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, bloating, belching, headache, dizziness, and fatigue.
Contraindications:
Injectable Wegovy should not be used in patients with a personal or family history of medullary thyroid carcinoma, MEN 2, or prior serious allergic reaction to semaglutide. Caution is also needed in patients with severe gastrointestinal symptoms, dehydration risk, pancreatitis concerns, or gallbladder disease.
Injectable Zepbound
Injectable Zepbound is a once-weekly tirzepatide injection FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related condition, in addition to reduced-calorie diet and increased physical activity. It is also approved for obstructive sleep apnea in certain adults with obesity.
How to take it:
Zepbound is given as a once-weekly injection. Treatment begins at a lower dose and is gradually increased based on tolerance and treatment response. It should be used exactly as prescribed.
Common side effects:
Common side effects may include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, belching, fatigue, injection site reactions, and reduced appetite.
Contraindications:
Zepbound should not be used in patients with a personal or family history of medullary thyroid carcinoma, MEN 2, or a serious hypersensitivity reaction to tirzepatide. It should be avoided during pregnancy. The labeling also notes that patients using oral hormonal contraceptives may need backup contraception for 4 weeks after starting Zepbound and after each dose increase.
